ITGAV and nasopharyngeal carcinoma: Genes ITGAV, FN1, and ITGB1 were shown to be the targets of miR-9-3p, which could inhibit proliferation and metastases of nasopharyngeal carcinoma by downregulating FN1, ITGB1, and ITGAV, thus inhibiting the EMT process35.